B
Composite 7.0 / 10
Last updated 2026-04-29. Composite is computed from the live database; missing sub-scores redistribute weight across the others.
Editorial summary
Manufacturer with focus on Tirzepatide. 9 tests averaging 8.6/10. Less Western community sentiment.
Peptide breakdown
| Peptide | Score | Lab quality | Tests | Purity | Qty var. | $/mg verified | Last test | Ranking |
|---|---|---|---|---|---|---|---|---|
| Tirzepatide | 8.6B+ |
8.6 | 9 | 99.0% | — | — | 2026-04-08 | view |
| Semaglutide | 7.5B |
7.5 | 8 | 98.9% | — | — | 2026-04-08 | view |
COA transparency
- ○ Publishes per-batch COAs (not just one COA for everyone) (pending)
- ○ Both HPLC and mass spec shown (pending)
- ○ Endotoxin or sterility data shown (pending)
- ○ At least one COA independently cross-checked (pending)
- ○ Most recent COA within 90 days (2026-02-20) (pending)
All vendor grades, side-by-side
Compare Shanghai JinBei Chemical against every other vendor in the grade hub →
Top-5 ranked vendors per peptide, plus the highest-rated vendors overall. Daily refresh.